Insider Buying: Medifast (NYSE:MED) Director Purchases $31,625.00 in Stock

Medifast Inc (NYSE:MED) Director Scott Schlackman acquired 2,500 shares of Medifast stock in a transaction on Friday, May 8th. The stock was purchased at an average price of $12.65 per share, with a total value of $31,625.00. Following the purchase, the director owned 28,049 shares of the company’s stock, valued at $354,819.85. The trade was a 9.79% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Scott Schlackman also recently made the following trade(s):

• On Monday, May 11th, Scott Schlackman acquired 2,500 shares of Medifast stock. The stock was purchased at an average price of $12.53 per share, with a total value of $31,325.00.

Medifast Trading Up 0.8%

Shares of NYSE MED opened at $12.59 on Friday. Medifast Inc has a twelve month low of $9.22 and a twelve month high of $15.46. The stock has a 50 day moving average of $10.74 and a two-hundred day moving average of $11.09. The stock has a market cap of $139.96 million, a P/E ratio of -6.88 and a beta of 0.55.

Medifast (NYSE:MED) last issued its quarterly earnings data on Monday, May 4th. The specialty retailer reported ($0.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.36. Medifast had a negative return on equity of 4.80% and a negative net margin of 5.78%.The company had revenue of $76.04 million during the quarter, compared to analysts’ expectations of $69.20 million. Medifast has set its FY 2026 guidance at -2.750–1.550 EPS and its Q2 2026 guidance at -1.000–0.500 EPS. As a group, research analysts predict that Medifast Inc will post -2 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Charles Schwab Investment Management Inc. grew its holdings in Medifast by 30.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 776,829 shares of the specialty retailer’s stock worth $8,297,000 after acquiring an additional 181,618 shares during the period. Bank of America Corp DE grew its holdings in Medifast by 14.2% during the third quarter. Bank of America Corp DE now owns 452,543 shares of the specialty retailer’s stock worth $6,186,000 after acquiring an additional 56,174 shares during the period. Dimensional Fund Advisors LP grew its holdings in Medifast by 10.9% during the first quarter. Dimensional Fund Advisors LP now owns 361,762 shares of the specialty retailer’s stock worth $3,686,000 after acquiring an additional 35,522 shares during the period. Lido Advisors LLC acquired a new position in Medifast during the third quarter worth $4,521,000. Finally, Steamboat Capital Partners LLC acquired a new position in Medifast during the fourth quarter worth $2,952,000. Institutional investors and hedge funds own 95.51% of the company’s stock.

Analyst Ratings Changes

MED has been the subject of several analyst reports. Wall Street Zen upgraded Medifast from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. Stephens cut their price target on Medifast from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Thursday, February 19th. Finally, Weiss Ratings cut Medifast from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 6th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Medifast has an average rating of “Reduce” and an average price target of $12.00.

About Medifast

Medifast, Inc (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight‐loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight‐management solutions.